cpasstm sars-cov-2 neutralization antibody detection kit omicron variant Search Results


90
GenScript corporation cpass™ sars-cov-2 neutralization antibody detection kit
Cpass™ Sars Cov 2 Neutralization Antibody Detection Kit, supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cpasstm+sars-cov-2+neutralization+antibody+detection+kit+omicron+variant/pmc11209143-55-6-5?v=GenScript+corporation
Average 90 stars, based on 1 article reviews
cpass™ sars-cov-2 neutralization antibody detection kit - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
GenScript corporation cpasstm sars-cov-2 neutralization antibody detection kit l00847-c
Cpasstm Sars Cov 2 Neutralization Antibody Detection Kit L00847 C, supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cpasstm+sars-cov-2+neutralization+antibody+detection+kit+omicron+variant/med_rxiv__2022__03__22__22272739-65-44-45?v=GenScript+corporation
Average 90 stars, based on 1 article reviews
cpasstm sars-cov-2 neutralization antibody detection kit l00847-c - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
GenScript corporation cpasstm sars-cov-2 neutralization antibody detection kit
Cpasstm Sars Cov 2 Neutralization Antibody Detection Kit, supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cpasstm+sars-cov-2+neutralization+antibody+detection+kit+omicron+variant/bio_rxiv__2022__03__21__485224-205-13-20?v=GenScript+corporation
Average 90 stars, based on 1 article reviews
cpasstm sars-cov-2 neutralization antibody detection kit - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
GenScript corporation ensaio imunoenzimático competitivo cpasstm sars-cov-2 neutralization antibody detection kit
Ensaio Imunoenzimático Competitivo Cpasstm Sars Cov 2 Neutralization Antibody Detection Kit, supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cpasstm+sars-cov-2+neutralization+antibody+detection+kit+omicron+variant/pmc09461030-4-16-27?v=GenScript+corporation
Average 90 stars, based on 1 article reviews
ensaio imunoenzimático competitivo cpasstm sars-cov-2 neutralization antibody detection kit - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
GenScript corporation svnt kit
Svnt Kit, supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cpasstm+sars-cov-2+neutralization+antibody+detection+kit+omicron+variant/pm36228670-42-21-30?v=GenScript+corporation
Average 90 stars, based on 1 article reviews
svnt kit - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
GenScript corporation surrogate neutralizing antibody to ancestral type (cpasstm)
Surrogate Neutralizing Antibody To Ancestral Type (Cpasstm), supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cpasstm+sars-cov-2+neutralization+antibody+detection+kit+omicron+variant/ppr0476306-45-27-29?v=GenScript+corporation
Average 90 stars, based on 1 article reviews
surrogate neutralizing antibody to ancestral type (cpasstm) - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
GenScript corporation cpasstm nas detection kits
Cpasstm Nas Detection Kits, supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cpasstm+sars-cov-2+neutralization+antibody+detection+kit+omicron+variant/pm36560535-46-18-22?v=GenScript+corporation
Average 90 stars, based on 1 article reviews
cpasstm nas detection kits - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
SG Medical Inc r-find sars-cov-2 neutralizing antibody elisa
Summary of immunogenicity of COVID-19 vaccination between healthy people and patients with end-stage renal disease
R Find Sars Cov 2 Neutralizing Antibody Elisa, supplied by SG Medical Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cpasstm+sars-cov-2+neutralization+antibody+detection+kit+omicron+variant/pmc09194491-199-48-50?v=SG+Medical+Inc
Average 90 stars, based on 1 article reviews
r-find sars-cov-2 neutralizing antibody elisa - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
Tetracore fleximmarraytm
Summary of immunogenicity of COVID-19 vaccination between healthy people and patients with end-stage renal disease
Fleximmarraytm, supplied by Tetracore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cpasstm+sars-cov-2+neutralization+antibody+detection+kit+omicron+variant/pmc09278177-4-6-6?v=Tetracore
Average 90 stars, based on 1 article reviews
fleximmarraytm - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

86
Abbott Laboratories advisedx sars cov 2 igg ii test
Summary of immunogenicity of COVID-19 vaccination between healthy people and patients with end-stage renal disease
Advisedx Sars Cov 2 Igg Ii Test, supplied by Abbott Laboratories, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cpasstm+sars-cov-2+neutralization+antibody+detection+kit+omicron+variant/pm41448096-52-3-8?v=Abbott+Laboratories
Average 86 stars, based on 1 article reviews
advisedx sars cov 2 igg ii test - by Bioz Stars, 2026-07
86/100 stars
  Buy from Supplier

90
EUROIMMUN sars-cov-2 neutralisa
Summary of immunogenicity of COVID-19 vaccination between healthy people and patients with end-stage renal disease
Sars Cov 2 Neutralisa, supplied by EUROIMMUN, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cpasstm+sars-cov-2+neutralization+antibody+detection+kit+omicron+variant/pmc09322013-55-27-29?v=EUROIMMUN
Average 90 stars, based on 1 article reviews
sars-cov-2 neutralisa - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
GenScript corporation cpasstm
Summary of immunogenicity of COVID-19 vaccination between healthy people and patients with end-stage renal disease
Cpasstm, supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cpasstm+sars-cov-2+neutralization+antibody+detection+kit+omicron+variant/pmc08608661-74-40-35?v=GenScript+corporation
Average 90 stars, based on 1 article reviews
cpasstm - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

Image Search Results


Summary of immunogenicity of COVID-19 vaccination between healthy people and patients with end-stage renal disease

Journal: Journal of Korean Medical Science

Article Title: Immunogenicity of COVID-19 Vaccination in Patients With End-Stage Renal Disease Undergoing Maintenance Hemodialysis: The Efficacy of a Mix-and-Match Strategy

doi: 10.3346/jkms.2022.37.e180

Figure Lengend Snippet: Summary of immunogenicity of COVID-19 vaccination between healthy people and patients with end-stage renal disease

Article Snippet: From serum and plasma samples, antibodies against the SARS-CoV-2 spike protein were quantified using Roche Elecsys ® Anti-SARS-CoV-2 S (Roche Diagnostics GmbH, Mannheim, Germany) and SARS-CoV-2 neutralizing antibodies were measured using both cPassTM SARS-CoV-2 Neutralization Antibody Detection Kit (GenScript USA Inc., Piscataway, NJ, USA) and R-FIND SARS-CoV-2 Neutralizing Antibody ELISA (SG Medical Inc., Seoul, Korea).

Techniques: Immunopeptidomics, Binding Assay, Activity Assay, Neutralization, Inhibition, Enzyme-linked Immunosorbent Assay

( A ) Binding antibody titer measured by Elecsys ® Anti-SARS-CoV-2 S. ( B ) Neutralizing antibody activity measured by cPass™ SARS-CoV-2 Neutralization Antibody Detection Kit. ( C ) Neutralizing antibody activity measured by R-FIND SARS-CoV-2 Neutralizing Antibody ELISA. ( D ) Proportion of participants with a positive result of binding antibody measured by Elecsys® Anti-SARS-CoV-2 S. ( E ) Proportion of participants with a positive result of neutralizing antibody measured by cPass™ SARS-CoV-2 Neutralization Antibody Detection Kit. ( F ) Proportion of participants with a positive result of neutralizing antibody measured by R-FIND SARS-CoV-2 Neutralizing Antibody ELISA. COVID-19 = coronavirus disease 2019, ESRD = end-stage renal disease, SARS-CoV-2 = severe acute respiratory syndrome coronavirus 2, ELISA = enzyme-linked immunosorbent assay, E = patients with ESRD, H = healthy people. a P values are the result of Mann–Whitney U test; b P values are the result of Wilcoxon signed-rank test; and c P values are the result of the Cochrane–Armitage test for trend.

Journal: Journal of Korean Medical Science

Article Title: Immunogenicity of COVID-19 Vaccination in Patients With End-Stage Renal Disease Undergoing Maintenance Hemodialysis: The Efficacy of a Mix-and-Match Strategy

doi: 10.3346/jkms.2022.37.e180

Figure Lengend Snippet: ( A ) Binding antibody titer measured by Elecsys ® Anti-SARS-CoV-2 S. ( B ) Neutralizing antibody activity measured by cPass™ SARS-CoV-2 Neutralization Antibody Detection Kit. ( C ) Neutralizing antibody activity measured by R-FIND SARS-CoV-2 Neutralizing Antibody ELISA. ( D ) Proportion of participants with a positive result of binding antibody measured by Elecsys® Anti-SARS-CoV-2 S. ( E ) Proportion of participants with a positive result of neutralizing antibody measured by cPass™ SARS-CoV-2 Neutralization Antibody Detection Kit. ( F ) Proportion of participants with a positive result of neutralizing antibody measured by R-FIND SARS-CoV-2 Neutralizing Antibody ELISA. COVID-19 = coronavirus disease 2019, ESRD = end-stage renal disease, SARS-CoV-2 = severe acute respiratory syndrome coronavirus 2, ELISA = enzyme-linked immunosorbent assay, E = patients with ESRD, H = healthy people. a P values are the result of Mann–Whitney U test; b P values are the result of Wilcoxon signed-rank test; and c P values are the result of the Cochrane–Armitage test for trend.

Article Snippet: From serum and plasma samples, antibodies against the SARS-CoV-2 spike protein were quantified using Roche Elecsys ® Anti-SARS-CoV-2 S (Roche Diagnostics GmbH, Mannheim, Germany) and SARS-CoV-2 neutralizing antibodies were measured using both cPassTM SARS-CoV-2 Neutralization Antibody Detection Kit (GenScript USA Inc., Piscataway, NJ, USA) and R-FIND SARS-CoV-2 Neutralizing Antibody ELISA (SG Medical Inc., Seoul, Korea).

Techniques: Binding Assay, Activity Assay, Neutralization, Enzyme-linked Immunosorbent Assay, MANN-WHITNEY

( A ) Binding antibody titer measured by Elecsys ® Anti-SARS-CoV-2 S. ( B ) Neutralizing antibody activity measured by cPass™ SARS-CoV-2 Neutralization Antibody Detection Kit. ( C ) Neutralizing antibody activity measured by R-FIND SARS-CoV-2 Neutralizing Antibody ELISA. ( D ) Change in the level of binding antibody between day 56 from the first dose and day 7 from the second dose measured by Elecsys ® Anti-SARS-CoV-2 S. ( E ) Change in the level of neutralizing antibody between day 56 from the first dose and day 7 from the second dose measured by cPass™ SARS-CoV-2 Neutralization Antibody Detection Kit. ( F ) Change in the level of neutralizing antibody between day 56 from the first dose and day 7 from the second dose measured by R-FIND SARS-CoV-2 Neutralizing Antibody ELISA. COVID-19 = coronavirus disease 2019, ESRD = end-stage renal disease, SARS-CoV-2 = severe acute respiratory syndrome coronavirus 2, ELISA = enzyme-linked immunosorbent assay, Vec = ChAdOx1, mRNA = BNT162b2, E = patients with ESRD, H = healthy people. a P values are the result of Mann–Whitney U test.

Journal: Journal of Korean Medical Science

Article Title: Immunogenicity of COVID-19 Vaccination in Patients With End-Stage Renal Disease Undergoing Maintenance Hemodialysis: The Efficacy of a Mix-and-Match Strategy

doi: 10.3346/jkms.2022.37.e180

Figure Lengend Snippet: ( A ) Binding antibody titer measured by Elecsys ® Anti-SARS-CoV-2 S. ( B ) Neutralizing antibody activity measured by cPass™ SARS-CoV-2 Neutralization Antibody Detection Kit. ( C ) Neutralizing antibody activity measured by R-FIND SARS-CoV-2 Neutralizing Antibody ELISA. ( D ) Change in the level of binding antibody between day 56 from the first dose and day 7 from the second dose measured by Elecsys ® Anti-SARS-CoV-2 S. ( E ) Change in the level of neutralizing antibody between day 56 from the first dose and day 7 from the second dose measured by cPass™ SARS-CoV-2 Neutralization Antibody Detection Kit. ( F ) Change in the level of neutralizing antibody between day 56 from the first dose and day 7 from the second dose measured by R-FIND SARS-CoV-2 Neutralizing Antibody ELISA. COVID-19 = coronavirus disease 2019, ESRD = end-stage renal disease, SARS-CoV-2 = severe acute respiratory syndrome coronavirus 2, ELISA = enzyme-linked immunosorbent assay, Vec = ChAdOx1, mRNA = BNT162b2, E = patients with ESRD, H = healthy people. a P values are the result of Mann–Whitney U test.

Article Snippet: From serum and plasma samples, antibodies against the SARS-CoV-2 spike protein were quantified using Roche Elecsys ® Anti-SARS-CoV-2 S (Roche Diagnostics GmbH, Mannheim, Germany) and SARS-CoV-2 neutralizing antibodies were measured using both cPassTM SARS-CoV-2 Neutralization Antibody Detection Kit (GenScript USA Inc., Piscataway, NJ, USA) and R-FIND SARS-CoV-2 Neutralizing Antibody ELISA (SG Medical Inc., Seoul, Korea).

Techniques: Binding Assay, Activity Assay, Neutralization, Enzyme-linked Immunosorbent Assay, MANN-WHITNEY